Regenerative Medicine and Disease Therapeutics
Regenerative pharmacology will have far higher development requirements. In fact, the challenges associated with regenerative pharmacology, i.e., curative therapeutics, will in many cases necessitate complex mixtures of compounds [i.e., growth factors such as fibroblast growth factor (FGF), epidermal growth factor (EGF), platelet-derived growth factor, nerve growth factor (NGF), vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), bone morphogenic proteins (BMPs These chemicals have far greater molecular weights (usually 10,000 to >100,000 mol. wt.) than those created historically by the pharmaceutical industry..